Search results
Results from the WOW.Com Content Network
[24] [note 3] By 2006, Wilber and Beck had diverged in their interpretations of the Spiral Dynamics model, with Beck positioning the spiral of levels at the center of the quadrants, while Wilber placed it solely in the lower left quadrant (e.g., the collective-intersubjective quadrant that relates to a culture's interpersonal values and beliefs ...
Kenneth Earl Wilber II (born January 31, 1949) is an American theorist and writer on transpersonal psychology and his own integral theory, [1] a four-quadrant grid which purports to encompass all human knowledge and experience.
A Theory of Everything: An Integral Vision for Business, Politics, Science, and Spirituality is a 2000 book by Ken Wilber detailing the author's approach, called Integral theory, to building a conceptual model of the World that encompasses both its physical and spiritual dimensions. He posits a unified ground-of-everything he calls Spirit.
Spiral Dynamics describes how value systems and worldviews emerge from the interaction of "life conditions" and the mind's capacities. [8] The emphasis on life conditions as essential to the progression through value systems is unusual among similar theories, and leads to the view that no level is inherently positive or negative, but rather is a response to the local environment, social ...
Sex, Ecology, Spirituality: The Spirit of Evolution is a 1995 book by American integral theorist Ken Wilber. Wilber intended it to be the first volume of a series called The Kosmos Trilogy, [citation needed] but subsequent volumes were never produced. The book has been both highly acclaimed by some reviewers and harshly criticized by others.
Business leaders warn of risks from inflationary tariffs and potential budget cuts at Goldman Sachs' Industrial and Materials conference.
Get 30% off all jewelry at Baublebar during the brand's sitewide Black Friday sale. Get 20% off custom items, too. Here are the pieces we recommend.
This strong market position generates substantial cash flows that support shareholder returns. Turning to the specifics, the pharmaceutical giant offers investors a 4.3% dividend yield backed by a ...